Latest

10.01.2021

Merck’s Covid-19 Drug Is a Boon for Wall Street and Main Street

Read Article
09.17.2021

Coherus and Junshi announces positive interim data for pivotal trial in esophageal cancer

Read Article
09.14.2021

CalciMedica Reports Topline Data from the Auxora CARDEA Phase 2 COVID-19 Pneumonia Clinical Trial

Read Article
09.09.2021

Why Atea Could Be the Frontrunner in the Covid Antiviral Race

Read Article
08.24.2021

Atea Pharmaceuticals Announces Publication of Data Highlighting AT-752’s Potent In Vitro and In Vivo Activity Against Dengue and O

Read Article
06.30.2021

Roche and Atea's small, early data peek sees experimental COVID drug slash viral load in hospital patients

Read Article
06.02.2021

CalciMedica Publishes Positive Data from Phase 2a Study of Auxora in Patients with Acute Pancreatitis and Announces First Patients

Read Article
03.31.2021

OncoResponse Raises $40.6 Million Series C Financing

Read Article
Up NextAbout Us